<DOC>
	<DOCNO>NCT02588417</DOCNO>
	<brief_summary>To evaluate effectiveness add dexamethasone intrathecal levobupivacaine combine spinal epidural ( CSE ) analgesia vaginal delivery .</brief_summary>
	<brief_title>Intrathecal Dexamethasone Labor Analgesia</brief_title>
	<detailed_description>This prospective double-blind trial include 80 primigravida vaginal delivery cervical dilatation ≥ 4 cm 50 % effacement randomly assign one two equal group ; Group L receive intrathecal levobupivacaine 0.25 % 2 mL Group LD receive intrathecal levobupivacaine 0.25 % combine dexamethasone 4 mg 2 mL . At first request analgesia , combination 0.25 % levobupivacaine 100 μg fentanyl 10 ml via epidural catheter . Further analgesia provide 7 ml 0.25 % levobupivacaine hourly . The primary outcome measure duration spinal analgesia . Secondary outcome measure include time spinal analgesia delivery , total amount epidurally administer levobupivicaine , adverse effect neuraxial block neonatal outcome .</detailed_description>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>ASA physical status I , II patient schedueled normal vaginal delivery age 1835 year old Patients refuse participate complicate pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>